Pilot Testing of a Colorectal Cancer Education Program
2 other identifiers
interventional
50
1 country
1
Brief Summary
The primary objective of this study is to assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, colorectal cancer (CRC) education program to improve CRC screening completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 21, 2026
CompletedFirst Posted
Study publicly available on registry
January 23, 2026
CompletedStudy Start
First participant enrolled
February 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2027
April 29, 2026
April 1, 2026
12 months
January 21, 2026
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CRC screening completion (yes/no)
Month 6
Secondary Outcomes (4)
Change in Brief Illness Perception Questionnaire (IPQ-B) score
Baseline, Month 6
Change in Medicines Questionnaire (BMQ) score
Baseline, Month 6
Change in number of barriers to care
Baseline, Month 6
Change in trust in health/community health workers
Baseline, Month 6
Study Arms (1)
Adults due for CRC screening who speak English or a Chinese language (Cantonese/Mandarin)
EXPERIMENTALParticipants will receive one CRC educational session, which will take around 1-1.5 hours.
Interventions
Culturally and linguistically tailored program consisting of community health worker (CHW)-led education sessions followed by patient navigation (PN) services.
Eligibility Criteria
You may qualify if:
- Age 45-75 years
- Not guideline concordant (no stool testing for CRC within past 1 year)
- No colonoscopy in past 10 years; no sigmoidoscopy or CT colonography in past 5 years)
- Understands English or Chinese languages.
- Willing and able to consent to participate
You may not qualify if:
- \) history of CRC or colectomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NYU Langone Healthlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Suzanne Vang
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2026
First Posted
January 23, 2026
Study Start
February 5, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
August 31, 2027
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to Suzanne.vang@nyulangone.org To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.
The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to Suzanne.vang@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.